Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Investors need to look past the name and realize that constant share dilution and weak track records at his previous counters make Salutica a risky bet for long-term value compared to companies with actual proven growth.
